Takeda executive granted 30,094 RSUs

Shannon Elaine Mary reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Shannon Elaine Mary reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical executive Shannon Elaine Mary, President of Global Supply & Quality, received an award of 30,094 American Depositary Shares in the form of restricted stock units. This is a compensation-related grant at a stated price of $0.00 per share, not an open‑market purchase.

Each RSU represents a contingent right to receive one American Depositary Share and will vest in three equal annual installments beginning on July 1, 2027. Following this award, Mary holds 87,674 American Depositary Shares directly, showing a larger equity stake tied to long-term performance and retention.

Insider Trade Summary

Grant/Award: 30,094 shares

Grant/Award 1 txn

Insider Shannon Elaine Mary

Role Pres., Global Supply & Quality

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	30,094	$0.00	$0.00

Holdings After Transaction: American Depositary Shares — 87,674 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Key Figures

RSUs granted: 30,094 shares Grant price: $0.00 per share Holdings after grant: 87,674 shares +2 more

5 metrics

RSUs granted 30,094 shares Restricted stock unit award of American Depositary Shares

Grant price $0.00 per share RSU award price

Holdings after grant 87,674 shares Total American Depositary Shares held directly post-transaction

Vest start date July 1, 2027 RSUs vest in three equal annual installments from this date

Transaction code A Grant, award, or other acquisition

Key Terms

restricted stock units, RSUs, American Depositary Shares, Grant, award, or other acquisition

4 terms

restricted stock units financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Takeda (TAK) executive Shannon Elaine Mary report in this Form 4?

Shannon Elaine Mary reported receiving a grant of 30,094 restricted stock units, each linked to one Takeda American Depositary Share. The award is compensation-related, carries a $0.00 grant price, and increases her directly held position to 87,674 ADS after the transaction.

How many Takeda (TAK) shares were granted to Shannon Elaine Mary?

She was granted 30,094 restricted stock units tied to Takeda American Depositary Shares. Each unit represents a right to receive one ADS in the future, subject to vesting conditions. This grant is recorded as an acquisition rather than an open-market share purchase.

When do Shannon Elaine Mary’s new Takeda (TAK) RSUs vest?

The RSUs vest in three equal annual installments beginning on July 1, 2027. This means the award will be delivered over three years, encouraging long-term alignment with shareholders and continued service as President of Global Supply & Quality at Takeda.

What is Shannon Elaine Mary’s total Takeda (TAK) holding after this transaction?

After the restricted stock unit grant, she directly holds 87,674 American Depositary Shares of Takeda. This figure reflects her position following the award and shows the scale of her equity-based compensation and ongoing alignment with company performance.

Is the Takeda (TAK) Form 4 transaction an open-market share purchase?

No, the transaction is a grant of restricted stock units, coded as an acquisition under Form 4 rules. The units were issued at a $0.00 price per share as compensation, not through buying Takeda shares on the open market at prevailing trading prices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shannon Elaine Mary

(Last) (First) (Middle)

45-55 HAYDEN AVENUE

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres., Global Supply & Quality

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A(1)		30,094	A	$0	87,674	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Remarks:

	/s/ Kate Huleatt, by power of attorney, for Elaine M. Shannon	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)